Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.59 |
| ▸ | MGLL | Q99685 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 9/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15437937 | 0.98 | MGLL (0.61) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL7110446 | 0.98 | MGLL (0.61) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL27661757 | 0.93 | TAAR1 (0.61) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL3800530 | 0.89 | TAAR1 (0.65) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL8402231 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL28176757 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL8401980 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL8401990 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL8398317 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 | |
| SCHEMBL8400524 | 0.86 | MGLL (0.66) | TAAR1MGLLMPOSLC6A4HSPA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2207877-A2 | MUTANT ENZYMES | ISIS Innovation Limited (GB) | 2010-07-21 | — | — | EP | disclosed |
| WO-2009047498-A2 | MUTANT ENZYMES | ISIS INNOVATION LIMITED (GB) | 2009-04-16 | — | — | WO | disclosed |
| WO-2007138381-A2 | PHOSPHONATED OXAZOLIDINONES AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS INC. (CA) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007120012-A1 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2007-10-25 | — | — | WO | disclosed |
| EP-1482931-A2 | MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE | Transtech Pharma, Inc. (US) | 2004-12-08 | — | — | EP | disclosed |
| EP-1456151-A1 | METHOD FOR FORMING A CARBON-CARBON OR CARBON-HETEROATOM LINKAGE | RHODIA CHIMIE (FR) | 2004-09-15 | — | — | EP | disclosed |
| WO-2004056763-A2 | NOVEL GLUCAGON ANTAGONISTS | NOVO NORDISK A/S (DK) | 2004-07-08 | — | — | WO | disclosed |
| WO-2003075921-A2 | MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE | TRANSTECH PHARMA, INC. (US) | 2003-09-18 | — | — | WO | disclosed |
| EP-1325388-A2 | AQUEOUS DEVELOPER FOR NEGATIVE WORKING LITHOGRAPHIC PRINTING PLATES | Kodak Polychrome Graphics GmbH (DE) | 2003-07-09 | — | — | EP | disclosed |
| WO-2003053885-A1 | METHOD FOR FORMING A CARBON-CARBON OR CARBON-HETEROATOM LINKAGE | RHODIA CHIMIE (FR) | 2003-07-03 | — | — | WO | disclosed |
| WO-2002031599-A2 | AQUEOUS DEVELOPER FOR NEGATIVE WORKING LITHOGRAPHIC PRINTING PLATES | KODAK POLYCHROME GRAPHICS COMPANY LTD. (US) | 2002-04-18 | — | — | WO | disclosed |